semaglutide swisschems Health Canada has approved the first generic injection for weight loss in Canada. The medication, called Svemia, is made by Canadian company Apotex and is the first generic version of Wegovy Novo Nordisk's semaglutide shortage officially

The company is investigating tirzepatide in patients with overweight and obesity who do not have type 2 diabetes, with Mounjaro poised to add the hot indication of chronic weight management to its label by the end of this year

Side effects Some common side effects of Semaglutide include: nausea, vomiting, diarrhea, abdominal pain, and constipation may occur

Bloating or Discomfort Backed-up food and waste in the gastrointestinal tract can lead to bloating, abdominal distension, and discomfort in people experiencing constipation during Ozempic therapy

So the practical summary for the article: no gap in treatment, no washout, but a strict one week from last injection rule (or next day when coming off the daily tablet), and never both at once

Direct Meds requires a medical consultation precisely to screen for contraindications